NEURONES: Organic growth up 10.6% over the first nine months of 2017
November 08 2017 - 10:40AM
PRESS INFORMATION
Heading: 3rd quarter 2017
revenues
Nanterre, November 8, 2017
Organic growth up
10.6% over the first nine months of 2017
|
(unaudited, in € millions) |
2016 |
2017 |
growth |
of which
organic (*) |
|
3rd quarter
revenues |
103.8 |
114 |
+9.8% |
+12.1% |
| Total as at
end-September |
325.3 |
359 |
+10.4% |
+10.6% |
Achievements
Despite significant recruitment
tensions and staff turnover that had risen sharply, over the first
nine months, NEURONES revenues grew 10.4% (up 10.6% at constant
scope of consolidation).
The operating profit (**) for the
3rd quarter
amounted to 9.6% and totaled 8.9% of revenues over the first nine
months of the year.
(*) in view of the change in scope of
consolidation as at May 31, 2017
(**) unaudited and after expenses of 0.2% related to bonus
shares
Outlook
Overall, for 2017, NEURONES
confirms its revenue forecast of over €480 million, with an
operating profit of between 9 and 9.5%.
About
NEURONES
With 5,000 experts, the NEURONES
group specializes in Consulting (Management, Organization and
Digital) and IT Services (Infrastructures and Applications). It
supports its clients in their change-management projects and in the
upgrading and outsourcing of their Information Systems.
Euronext Paris (Compartment B -
NRO) - Enternext Tech 40
www.neurones.net
Press Relations:
Florence Gillier Communication
Sabine Grosdidier
+33 (0)1 41 18 85 55
sabineg@fgcom.fr |
NEURONES
Matthieu Vautier
+33 (0)1 41 37 41 37
rp@neurones.net |
Investor Relations:
NEURONES
Paul-César Bonnel
+33 (0)1 41 37 41 37
investisseurs@neurones.net |
|
NEURONES - Q3 2017
revenues
This
announcement is distributed by Nasdaq Corporate Solutions on behalf
of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely
responsible for the content, accuracy and originality of the
information contained therein.
Source: NEURONES via Globenewswire
Neurones (EU:NRO)
Historical Stock Chart
From Dec 2024 to Jan 2025
Neurones (EU:NRO)
Historical Stock Chart
From Jan 2024 to Jan 2025
